We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk

News   Sep 05, 2016

 
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
 
 
Advertisement
 

RELATED ARTICLES

Genetic Variation, Chromatin Accessibility and Neuropsychiatric Disorders

News

A new study took a novel approach to identifying SNPs influencing the risk of neuropsychiatric disorders like schizophrenia, bipolar and major depressive disorder.

READ MORE

Blood Test Could Diagnose Baby Brain Damage Just Hours After Birth

News

A newly developed blood test could detect which babies deprived of oxygen at birth are at risk of serious neurodisabilities like cerebral palsy and epilepsy.

READ MORE

Two New Rapid COVID-19 Tests To Be Rolled Out in the UK Ahead of Winter

News

Millions of new rapid coronavirus tests will be rolled out across NHS hospitals, care homes and labs from next week. Both tests will be able to detect COVID-19 and other winter viruses in just 90 minutes and will hugely increase testing capacity ahead of winter.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE